Skip to main content

ADVERTISEMENT

risk factors

Case Study
05/01/2024
Wound Management & Prevention
Original Research
04/14/2023
Aishu Ramamurthi
Hunter S. Cameron
Christina Megal
Marc de Moya
Jacob Peschman
In a retrospective analysis of 448 patients, a violent mechanism of spinal cord injury was found to be a significant predictor of the development of one or more pressure injuries.
In a retrospective analysis of 448 patients, a violent mechanism of spinal cord injury was found to be a significant predictor of the development of one or more pressure injuries.
In a retrospective analysis of...
04/14/2023
Wounds
Review
11/10/2022

Emily Greenstein, APRN, CNP, CWON-AP, FACCWS1; Maarten Vooijs, MSc2; and Sarah Norton, MSN, MBA, RN, CWCN3

Emily Greenstein, APRN, CNP, CWON-AP,...
This article aims to offer a simplified yet practical summary for the prevention and management of exudate pooling by using advanced wound dressings.
This article aims to offer a simplified yet practical summary for the prevention and management of exudate pooling by using advanced wound dressings.
This article aims to offer a...
11/10/2022
Wound Management & Prevention
Basics of Wound Care
02/03/2022
Christopher M. Davey, MD, CWSP
A basic overview of pressure injuries including risk factors and staging.
A basic overview of pressure injuries including risk factors and staging.
A basic overview of pressure...
02/03/2022
Wound Management & Prevention
Empirical Studies
01/03/2022
Mei-Yu Hsu, MS
Hsiao-Hui Hsu, MS
Yu-Lin Wu, PhD, RN, WCET
A prospective cohort study to determine incidence rates and predictors of stomal and peristomal complications.
A prospective cohort study to determine incidence rates and predictors of stomal and peristomal complications.
A prospective cohort study to...
01/03/2022
Wound Management & Prevention
Original Research
11/02/2021
Itaricely Istolé Castro de Assis, RN
Jonathan Estevam dos Santos, RN
Maria Luiza Valadares Sinicio Abib, RN
Luana Furtado Bueno, RN, MD
Manuela de Mendonça Figueirêdo Coelho, RN, CETN, MD, PhD
Daniel Nogueira Cortez, RN, MD, PhD
Juliano Teixeira Moraes, RN, CETN, MD, PhD
11/02/2021
Wound Management & Prevention
Empirical Research
09/01/2021
Bing-Bing Wu
Dong-Zhou Gu
Jia-Ning Yu
Li-Ping Feng, MS
Rong Xu
Man-Li Zha, MS
Wang-Qin Shen, PhD
Hong-Lin Chen, PhD
09/01/2021
Wound Management & Prevention
Empirical Studies
06/04/2021
Emel Yılmaz, PhD
Arzu Aslan Başlı, RN, PhD
To determine the rate of intraoperative pressure injuries and evaluate risk factors in surgical patients, a descriptive study was conducted among patients older than 18 years of age undergoing a nonemergent (planned) surgical procedure...
To determine the rate of intraoperative pressure injuries and evaluate risk factors in surgical patients, a descriptive study was conducted among patients older than 18 years of age undergoing a nonemergent (planned) surgical procedure...
To determine the rate of...
06/04/2021
Wound Management & Prevention
Original Contribution
12/28/2018

Dinu Valentin Balanescu, MD1*;  Dominique J Monlezun, MD1,2*;  Teodora Donisan, MD1,3;  David Boone, MD2;  Frances Cervoni-Curet, MD2;  Nicolas Palaskas, MD1;  Juan Lopez-Mattei, MD1;  Peter Kim, MD1;  Cezar Iliescu, MD1;  Serban Mihai Balanescu, MD

 

Dinu Valentin Balanescu, MD1*;  Domin...
We assessed the cardiovascular risk profile and coronary angiography findings of 240 cancer patients and 240 patients without cancer to compare the burden of angiographically detected coronary atherosclerosis.
We assessed the cardiovascular risk profile and coronary angiography findings of 240 cancer patients and 240 patients without cancer to compare the burden of angiographically detected coronary atherosclerosis.
We assessed the cardiovascular...
12/28/2018
Journal of Invasive Cardiology
Research in Review
05/30/2017
JCP Editors
Patients with human epidermal growth factor 2 (HER2)-positive breast cancer who undergo induction chemotherapy are likely to convert to HER2-negative disease if residual disease occurs, prompting further systemic...
Patients with human epidermal growth factor 2 (HER2)-positive breast cancer who undergo induction chemotherapy are likely to convert to HER2-negative disease if residual disease occurs, prompting further systemic...
...
05/30/2017
Journal of Clinical Pathways